Displaying drugs 951 - 975 of 2785 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Thallous chloride | 239.836 ClTl | A diagnostic radiopharmaceutical for myocardial perfusion testing and tests of parathyroid function. | Radioactive Diagnostic Agent | |
Xenon-133 | 132.9059 Xe | An inhaled radionuclide used to measure lung function and organ blood flow. | Inhalation Diagnostic Agent | |
Technetium Tc-99m pertechnetate | 169.968 H8O4Tc | A radiocontrast agent used for the identification of various organs, including but not limited to the brain, thyroid, placenta, and bladder. | Thyroid Diagnostic Radiopharmaceuticals | |
Ioxaglic acid | 1268.886 C24H21I6N5O8 | A tri-iodinated benzoate contrast agent used in various radiological procedures including angiography, phlebography, urography, computed tomography (CT), and hysterosalpingography. | Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media | |
Chondroitin sulfate | Not Available | Chondroitin sulfate, used with glucosamine, is indicated to alleviate pain and inflammation from primary osteoarthritis. This supplement is reported to improve joint function and slow disease progression. Osteoarthritis is characterized... | Chondroitin | |
Butylscopolamine | 360.473 C21H30NO4 | An antispasmodic and anticholinergic agent used for the symptomatic treatment of abdominal cramping and pain. | Belladonna Alkaloids, Semisynthetic, Quaternary Ammonium Compounds | |
Tenofovir alafenamide | 476.474 C21H29N6O5P | A nucleoside analog reverse transcriptase inhibitor used for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease. | Antiviral Agents / Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor / Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor / Nucleoside and Nucleotide Reverse Transcriptase Inhibitors | |
Paritaprevir | 765.89 C40H43N7O7S | A direct acting antiviral agent used in combination with other antiviral agents for the treatment of Hepatitis C Virus (HCV) infections. | Antivirals for treatment of HCV infections | |
Ombitasvir | 894.127 C50H67N7O8 | A direct acting antiviral agent used in combination with other antiviral agents for the treatment of Hepatitis C Virus (HCV) infections. | Antivirals for treatment of HCV infections | |
Iodide I-131 | 130.9067 I | A radioisotopic agent used for the treatment of hyperthyroidism and thyroid carcinomas that take up iodine. | Iodine (131I) Compounds | |
Sacubitril | 411.498 C24H29NO5 | A neprilysin inhibitor used in combination with valsartan as an adjunct to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction. | Neprilysin Inhibitor / Neprilysin, antagonists & inhibitors | |
Rolapitant | 500.485 C25H26F6N2O2 | A neurokinin-1 (NK-1) receptor antagonist used in combination with other antiemetics for the prevention of delayed nausea and vomiting associated with emetogenic chemotherapy. | Neurokinin-1 Receptor Antagonists / Substance P/Neurokinin-1 Receptor Antagonist | |
Polyethylene glycol | Not Available | A laxative used to treat constipation and used for bowel preparation before colonoscopies and other procedures. | Electrolytes / Ethylene Glycols / Excipients / Laxatives / Osmotic Laxatives / Polyethylene Glycols / Polymers / Solvents / Surface-Active Agents | |
Molsidomine | 242.235 C9H14N4O4 | A long-acting vasodilator used to treat angina pectoris, including in association with left heart failure and acute myocardial infarction. | Morpholines / Nitric Oxide Donors / Sydnones / Vasodilating Agents | |
Magnesium trisilicate | 260.857 Mg2O8Si3 | An antacid used for the symptomatic treatment of peptic ulcers. | Antacids / Laxatives | |
Lumacaftor | 452.414 C24H18F2N2O5 | A protein chaperone used in combination with ivacaftor for the treatment of cystic fibrosis in patients who are homozygous for the F508del mutation in the CFTR gene. | Amines / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Inducers / Cytochrome P-450 CYP2C19 Inducers (strength unknown) / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (strength unknown) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inducers (strong) / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strong) / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Dioxoles / Heterocyclic Compounds, Fused-Ring / P-glycoprotein inducers / P-glycoprotein inhibitors / Pyridines | |
Activated charcoal | 12.011 C | A gastric decontamination agent used in emergency clinical settings as a antidote to treat poisonings following excessive oral ingestion of certain medications or poisons. | Charcoal Preparations | |
Choline C 11 | 138.62 C5H14ClNO | Choline C11 is indicated for its use in positron emission tomography (PET) imaging in patients with suspected prostate cancer recurrence and non-informative bone scintigraphy, computerized tomography or magnetic resonance imaging.[FDA... | Drugs that are Mainly Renally Excreted | |
Sodium aurothiomalate | 390.07 C4H3AuNa2O4S | A disease-modifying antirheumatic drug (DMARD) indicated for the symptomatic treatment of arthritis. | Gold Preparations | |
Bismuth subcitrate potassium | 780.654 C12H8BiK5O14 | A colloid used for the treatment of peptic ulcer and gastro-esophageal reflux disease (GERD). | Neurotoxic agents | |
Artesunate | 384.425 C19H28O8 | Artesunate is an artemesinin derivative indicated for the initial treatment of severe malaria. | Artemisinin and derivatives | |
Eluxadoline | 569.662 C32H35N5O5 | A mixed mu-opioid receptor agonist used to treat irritable bowel syndrome with diarrhea. | Antipropulsives / Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome | |
Ubidecarenone | 863.3435 C59H90O4 | A cofactor found in various dietary supplements. | Electron Transport Chain Complex Proteins / Ubiquinone / Vitamins | |
Phenylacetic acid | 136.1479 C8H8O2 | An agent used as an adjunct to treat acute hyperammonemia and associated encephalopathy in adult and pediatric patients with deficiencies in enzymes of the urea cycle. | Various Alimentary Tract and Metabolism Products | |
Picosulfuric acid | 437.44 C18H15NO8S2 | A stimulant laxative used for cleansing of the colon as a preparation for colonoscopy in adults. | Laxatives |
Displaying drugs 951 - 975 of 2785 in total